EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Sophia Karagiannis

United Kingdom

Sophia Karagiannis

B cell immunologist with academic and biotechnology experience, focused on developing antibodies and antibody-drug conjugates for cancer therapy and dissecting humoral immunity in tumours. First to design and translate IgE therapies for cancer to clinical testing and founder of Epsilogen Ltd.

Sessions

Saturday 14 Jun

17:45 - 19:15
SY18 Th2 immune responses and clinical outcomes Symposium Hall 1

Sunday 15 Jun

13:00 - 13:30 AllergoOncology: Connecting Allergology and Cancer Research

15:00 - 16:30
FT16 Immunodeficiencies and autoimmunity Flash Talks Dochart 1

EAACI Congress 2025 Back

Sessions

Share this pen